Biotech Values

[DewDiligence]

How do we know mnta has met all its obligations to the fda?

We don’t know that, but it’s a reasonable inference. We do know the FDA has had NVS/MNTA’s response to the immunogenicity questions in hand for more than one year and has not made a new request that meets the threshold of materiality for disclosure purposes.